Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis (Q113891643)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis |
clinical trial |
Statements
Clinical Evaluation of Two Different Dosage Groups of Tacrosolv Eye Drops in a Placebo Controlled Crossover Design to Evaluate Safety and Efficacy in Patients Suffering From Grass Pollen Induced Allergic Rhinoconjunctivitis in the Vienna Challenge Chamber. (English)
0 references
4 August 2020
0 references
27 May 2021
0 references
64
0 references
18 year
0 references
65 year
0 references